Infectious Disease and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France; Infectious Diseases, Centre Hospitalier Bretagne-Atlantique, Vannes, France.
Hepatology and Liver Transplantation, Pontchaillou University Hospital, Rennes, France.
Infect Dis Now. 2024 Apr;54(3):104869. doi: 10.1016/j.idnow.2024.104869. Epub 2024 Feb 23.
Liver transplant recipients are at risk of tuberculosis, which is particularly difficult-to diagnose and to treat in this population.
Retrospective study of all cases of tuberculosis diagnosed from 2007 to 2022 in the French network of liver transplant sites.
Twenty-three liver transplant recipients were diagnosed with tuberculosis (six females, median age 59 years [interquartile range, 54-62]), with a median time lapse of 10 months [5-40.5] after transplant, and 38 days [26-60] after symptoms onset. Primary modes of pathogenesis were latent tuberculosis reactivation (n = 15) and transplant-related transmission (n = 3). Even though most patients with pre-transplant data had risk factors for tuberculosis (11/20), IFN-gamma release assay was performed in only three. Most cases involved extra-pulmonary tuberculosis (20/23, 87 %). With median follow-up of 63 months [24-108], five patients died (22 %), including four tuberculosis-related deaths.
Extrapulmonary tuberculosis is a severe disease in liver transplant recipients. Systematic pre-transplant screening of latent tuberculosis may prevent most of them.
肝移植受者存在罹患结核病的风险,而在该人群中,结核病的诊断和治疗特别具有挑战性。
对 2007 年至 2022 年期间法国肝移植中心网络中诊断的所有结核病病例进行回顾性研究。
共诊断出 23 例肝移植受者患有结核病(6 名女性,中位年龄 59 岁[四分位距,54-62]),移植后中位时间为 10 个月[5-40.5],症状出现后中位时间为 38 天[26-60]。主要发病模式为潜伏性结核再激活(n=15)和与移植相关的传播(n=3)。尽管大多数具有移植前数据的患者存在结核病风险因素(11/20),但仅对 3 例进行了干扰素-γ释放试验。大多数病例为肺外结核病(20/23,87%)。中位随访时间为 63 个月[24-108],5 例患者死亡(22%),包括 4 例与结核病相关的死亡。
肺外结核病是肝移植受者的严重疾病。系统的移植前潜伏性结核病筛查可能会预防其中大多数患者。